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Abstract
Objective: The study aimed to evaluate the homocysteine and cobalamin status of
German vegans and determine whether the intake of very small amounts of foods of
animal origin can improve this status.
Design and setting: Cross-sectional study, Germany.
Subjects: The dietary and nutritional intakes of 131 vegans (73 women, 58 men; age
range: 20.2–82.1 years) were evaluated using a general questionnaire and two food-
frequency questionnaires.
Results: The prevalence of inadequate cobalamin status in volunteers of the German
Vegan Study was 28.2%, and that of hyperhomocysteinaemia, 38.1%. Moderate
vegans were affected to a lesser extent than were strict vegans. Duration of veganism
and cobalamin concentration were inversely correlated (Spearman’s r ¼ 20.175,
P ¼ 0.047). Folate concentration and erythrocyte aspartic acid aminotransferase
activity were not correlated with plasma homocysteine concentration, but duration of
veganism correlated positively with homocysteine concentration (Spearman’s
r ¼ 0.319, P , 0.001). Cobalamin and homocysteine concentrations were inversely
correlated (when controlling for duration of veganism; r ¼ 20.602, P , 0.001).
Conclusion: Cobalamin status needs to be improved in order to minimise the risk of
hyperhomocysteinaemia.
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Hyperhomocysteinaemia is considered to be an indepen-
dent risk factor for vascular diseases of the coronary,
cerebral and peripheral arteries. An increase in total
plasma homocysteine of only 5mmol l21 is estimated to
result in a 50–80% increased risk for cerebrovascular or
coronary artery disease1. To date, no standardised
definition of hyperhomocysteinaemia exists2,3. Elevated
plasma homocysteine concentration results from either
genetic defects and/or nutritional deficiencies of the
vitamins involved in the metabolism of homocysteine:
pyridoxine, cobalamin and folic acid. Selhub et al.3
estimated that at least two-thirds of cases of hyperhomo-
cysteinaemia are due to inadequate cobalamin, pyridoxine
or folate status.
In general, omnivores obtain a sufficient supply of
cobalamin – with the exception of sufferers of chronic
atrophic gastritis – since meat and animal products are
reliable sources for the vitamin. However, omnivores may
have low folate intakes due to lower vegetable intake.
Hyperhomocysteinaemia in healthy omnivores is there-
fore more likely to be related to low folate intake rather
than to cobalamin deficiency4. In vegetarians and
especially in vegans, a different situation can be assumed.
Owing to the absence of cobalamin in plant foods (unless
contaminated with faecal matter or fortified), vegans are
more likely to be at risk of cobalamin deficiency but show
high folate intakes and blood folate concentrations5–9,
whereas lacto-ovo vegetarians consume reasonable
amounts of cobalamin in the form of eggs and/or dairy
products10–12. The strongest inverse association between
cobalamin and homocysteine concentration is found in
vegetarians, whereas in omnivores the (inverse) associ-
ation between folic acid and homocysteine is the stronger
one7,13–15.
In order to investigate the cobalamin and homocysteine
status of German vegans and to evaluate whether the
consumption of small amounts of eggs and dairy products
can improve cobalamin status (and decrease homocys-
teine concentrations), strict and moderate vegans were
included in the German Vegan Study (GVS).
Methods
Subjects for the GVS (designed as a cross-sectional study)
were recruited by means of advertisements. Dietary
intakes and nutritional intakes were evaluated by means
of a general questionnaire and two 9-day food-frequency
questionnaires. The GVS cohort was subdivided into strict
and moderate vegans according to dietary intake: strict
vegans (SV) consuming a pure vegan diet and moderate
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vegans (MV) consuming a maximum of 5% of total energy
from eggs and/or dairy products. The following data
illustrate that the dietary intake of moderate vegans was
much more similar to that of the strict vegans than to the
dietary intake of lacto-ovo vegetarians, and that it made
more sense to name them moderate vegans rather than
restricted lacto-ovo vegetarians. They consumed only very
small amounts of products of animal origin: the mean daily
intake was 4.05 g of milk, 1.64 g of butter, 1.48 g of cheese
and 0.95 g of eggs16.
Altogether, 131 persons (who took no cobalamin
supplements) participated in all study segments and
fulfilled the following study criteria: ‘strict’ vegan diet
(n ¼ 86) or ‘moderate’ vegan diet (n ¼ 45) for at least
1 year prior to the start of the study, minimum age of
18 years and no pregnancy or childbirth during the
previous 12 months.
An automated chemiluminescence system (ACS:180;
Ciba Corning, Fernwald, Germany) was used to measure
plasma cobalamin and red blood cell (RBC) folate
concentrations17–19. Plasma homocysteine concentrations
were measured by high-performance liquid chromatog-
raphy (Immunodiagnostic AG, Bensheim, Germany)20.
Pyridoxine status was analysed by measuring the
erythrocyte aspartic acid aminotransferase (EAST) activity
after stimulation (EPOS Analyzer 5060; Eppendorf,
Hamburg, Germany)21. The haemoglobin-cyanide
method was used to measure haemoglobin22–24, and
RBC mean cell volume (MCV) was determined with a
Coulterw STKS (Beckman Coulter; VCS Technology,
Krefeld, Germany).
Ethical considerations
The GVS was conducted in accordance with the
Helsinki Declaration of 1964 as revised in 1983 and
1996. Since there was no intervention, the Ethics
Commission of Lower Saxony confirmed that ethical
approval was not required. All subjects participated
voluntarily and gave written consent prior to starting
the study.
Statistical analysis
A statistical analysis program (SPSS 10.0.7; SPSS, Inc.,
Chicago, IL, USA) was used to analyse the data. Results are
shown as mean ^ standard deviation or median (5th/95th
percentile). Normal distribution of the data was checked
using the Kolmogorov–Smirnov test. In the case of
skewness, the Mann–Whitney U-test was used to reveal
significant differences between the two groups; given a
normal distribution the independent-samples t-test was
used. For nominal data the chi-square test was used to
evaluate statistically significant differences. Partial corre-
lation was used to detect associations between (log)
cobalamin and (log) homocysteine plasma concentrations
while controlling for the duration of vegan diet. The
relative risks of suffering from marginal pyridoxine supply
and of being cobalamin-deficient were computed by
means of incidence rates. As the results were not
influenced by age, the calculations were not adjusted for
age. Statistical significance was set at the 0.05 level;
significance levels quoted are two-sided.
Results
Characteristics of the study participants
The characteristics of the GVS participants with respect to
dietary subgroup allocation are shown in Table 1.
Homocysteine, cobalamin, folate and pyridoxine
Table 2 shows that homocysteine concentrations were
significantly higher and cobalamin concentrations were
significantly lower in strict vegans than in moderate
vegans. The median plasma concentration of homocys-
teine in the GVS cohort was 12.7mmol l21. However,
homocysteine concentrations were significantly higher
(P , 0.001, Mann–Whitney U-test) in men (median:
15.9mmol l21) than in women (median: 10.6mmol l21).
The prevalence of homocysteine concentration
$15mmol l21 was 38.1% (SV: 45.3%, MV: 24.4%, men:
55.2%, women: 24.7%). About two-thirds of the cohort
showed homocysteine concentrations $10mmol l21
(SV: 70.9%, MV: 62.2%, men: 82.8%, women: 56.2%).
Homocysteine concentration increased with the duration
of following a vegan diet (Spearman’s r ¼ 0.319,
P , 0.001). No association was found between homo-
cysteine and age. After controlling for the duration of
veganism, the correlation between (log) cobalamin and
(log) homocysteine was strong, inverse and statistically
Table 1 Characteristics of participants in the German Vegan Study (values are expressed as mean ^ standard
deviation)
Strict vegans (n ¼ 86) Moderate vegans (n ¼ 45) P-value
Males/females (%) 48.8/51.2 35.6/64.4 0.146*
Age (years) 43.8 ^ 15.6 44.6 ^ 15.0 0.762†
Body mass index (kg m22) 21.5 ^ 2.66 21.3 ^ 2.11 0.699†
Duration of vegan diet (years) 7.14 ^ 6.69 4.69 ^ 2.97 0.072‡
Energy intake (MJ day21) 8.60 ^ 3.05 7.35 ^ 2.16 0.016†
Energy derived from products of animal origin (%) 0.00 1.17 ^ 1.07 < 0.001†
* Chi-square test.
† Independent-samples t-test.
‡ Mann–Whitney U-test.
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significant (r ¼ 20.602, P , 0.001). In the German Vegan
Study, homocysteine concentrations were not associated
with folate and pyridoxine values (data not shown). The
median plasma cobalamin concentration of the GVS
cohort was 147 pmol l21. Men showed statistically signifi-
cant lower median plasma cobalamin concentrations than
did women (P ¼ 0.003, Mann–Whitney U-test), at 123 and
165 pmol l21, respectively; and moderate vegans showed
higher median plasma cobalamin concentrations than
strict vegans (Table 2). Only 14.5% of the GVS cohort had
plasma cobalamin concentrations .258 pmol l21 (SV:
8.14%, MV: 26.7%), whereas the prevalence of values
,110 pmol l21 was 28.2% (SV: 39.5%, MV: 6.67%). The
relative risk of being cobalamin-deficient (,110 pmol l21)
was 5.93 for strict vegans compared with moderate
vegans. Using the higher cut-off point of #156 pmol l21
for cobalamin deficiency, more than half of the cohort
would be classified as deficient (SV: 65.5%, MV: 37.8%).
The duration of following a vegan diet was inversely
associated with plasma cobalamin concentration (Spear-
man’s r ¼ 20.175, P ¼ 0.047). The relative risk of being
cobalamin-deficient was 1.81 for long-term vegans
($5 years) compared with short-term vegans (,5
years). Additional signs of cobalamin deficiency are
decreased haemoglobin concentration (,120 g l21 for
females,,140 g l21 for males) and elevated MCV (.96 fl).
Concentrations of homocysteine and haemoglobin and
MCV levels of the cobalamin-deficient subgroup
(,110 pmol l21) are shown in Table 3. It is obvious that
more strict vegans than moderate vegans suffered from
cobalamin deficiency. Nearly three-quarters of the sub-
group show stage III cobalamin deficiency and about half
show stage IV cobalamin deficiency.
In the GVS cohort folate concentrations were compara-
tively high in both groups, with slightly higher median
concentrations in moderate vegans than in strict vegans.
The prevalence of high EAST activity values (.1.85;
indicating a low pyridoxine status) was 21.8% in strict
vegans and 13.2% in moderate vegans. The relative risk of
marginal pyridoxine supply was 1.65 for strict vegans
compared with moderate vegans.
Discussion
In this study, the plasma homocysteine, cobalamin, folate
and pyridoxine concentrations of German vegans were
investigated. The GVS cohort was subdivided according to
dietary intake into strict vegans (SV) and moderate vegans
(MV). These subgroups did not differ in anthropometric
data or the duration of following a vegan diet16. Previous
data2,5 have suggested that a vegetarian/vegan diet is
related to elevated plasma homocysteine concentrations
that lower the benefits of these diets regarding cardiovas-
cular disease (CVD). From epidemiological studies it is
known that there is an association between hyperhomo-
cysteinaemia and the occurrence of myocardial infarcts.
Despite the fact that there are no data to show that an
elevated homocysteine concentration is a causative factor
in the development of atherosclerosis, some authors
consider hyperhomocysteinaemia to be an important and
independent risk factor for CVD1,25. The ‘normal’ range
for total plasma homocysteine25,26 is approximately
5–15mmol l21, while plasma homocysteine concentration
in the range of 15–30mmol l21 is considered to indicate
moderate hyperhomocysteinaemia25,27. Stein and
McBride26 have suggested that the upper limit of
15mmol l21 for normal plasma homocysteine values
should be revised to lower values, since the risk of
atherosclerosis is already increased within this range. Cut-
off points of 12mmol l21 (reference 27) and 10mmol l21
(reference 28) have been discussed as upper levels for
plasma homocysteine.
In the cohort investigated, the prevalence of plasma
homocysteine concentration .15mmol l21 was 36%. The
incidence of hyperhomocysteinaemia was higher for strict
vegans than for moderate vegans and higher for men than
Table 2 Status of homocysteine and related vitamins of partici-
pants in the German Vegan Study (values are expressed as
median (5th/95th percentile))
Strict vegans
(n ¼ 86)
Moderate vegans
(n ¼ 45) P-value
Homocysteine
(mmol l21)
13.4 (6.03/82.5) 12.3 (4.61/23.6) 0.022*
Males 11.2 (5.14/60.9) 10.3 (4.35/23.5) 0.200*
Females 17.3 (6.15/85.8) 14.3 (5.50/36.0) 0.124*
Cobalamin
(pmol l21)
122 (71.2/276) 185 (97.6/689) < 0.001*
Males 138 (88.0/373) 199 (107/765) 0.011†
Females 113 (65.2/274) 151 (87.1/490) 0.021†
Folate
(nmol l21)
33.6 (19.4/46.3) 35.1 (18.9/45.3) 0.925†
Males 35.9 (20.9/45.5) 36.3 (19.4/45.8) 0.865†
Females 32.8 (17.9/46.6) 30.4 (11.6/45.3) 0.631†
EAST activity 1.60 (1.30/2.00) 1.60 (1.15/1.98) 0.730*
Males 1.60 (1.31/2.05) 1.60 (1.10/1.95) 0.097†
Females 1.50 (1.30/2.00) 1.60 (1.40/2.00) 0.260*
EAST – erythrocyte aspartic acid aminotransferase.
* Mann–Whitney U-test.
† Independent-samples t-test.
Table 3 Homocysteine, mean cell volume (MCV) and haemo-
globin in the cobalamin-deficient subgroup of participants in the
German Vegan Study (values are expressed as median (5th/95th
percentile))
Strict vegans
(n ¼ 34)
Moderate
vegans (n ¼ 3)
Homocysteine (mmol l21) 22.7 (8.40/110) 16.6 (15.9/23.9)
. 15mmol l21 n ¼ 24 n ¼ 3
. 10mmol l21 n ¼ 31 n ¼ 3
MCV (fl) 96.5 (80.8/110) 87.0 (85.0/91.0)
. 96 fl n ¼ 17 n ¼ 0
Haemoglobin (g l21) 140 (120/163) 135 (134/140)
Females ,120 g l21,
Males , 140 g l21
n ¼ 5 n ¼ 1
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for women. The prevalence of homocysteine concen-
tration .10mmol l21 was 67%. Again, more strict vegans
than moderate vegans and more men than women
showed homocysteine concentrations above this cut-off
point. Krajcovicova-Kudlackova et al.5 reported a preva-
lence of hyperhomocysteinaemia (.15mmol l21) of 53%
among vegans and 29% among vegetarians. Their mean
homocysteine concentrations of 15.8 and 13.2mmol l21,
respectively, were higher than in the GVS cohort.
Herrmann et al.2 documented similar median homocys-
teine concentrations: 15.2mmol l21 for vegans and
11.0mmol l21 for lacto-ovo vegetarians, and the preva-
lence of homocysteine concentration .15mmol l21 was
57% and 12%, respectively. Homocysteine concentrations
of ,8mmol l21 are desirable for the prevention of CVD29
and were prevalent in 23% of the GVS cohort. More
moderate vegans than strict vegans and more women than
men were in this desirable range of,8mmol l21 (Table 2).
In accordance with the findings from other studies3,30,
men in our study showed statistically significant higher
plasma homocysteine concentrations than did women
(difference: 5mmol l21, P , 0.001, Mann–Whitney U-test).
This may partly be due to a difference in vitamin status,
since significant differences were found for cobalamin
plasma concentrations (difference: 50 pmol l21, P ¼ 0.005,
Mann–Whitney U-test), but also reflects the influence of
17b-oestradiol25,31. Correlations between the dietary
intakes of cobalamin, folate and pyridoxine and corres-
ponding plasma concentrations were not found.
In contrast to the hyperhomocysteinaemia in omni-
vores, the higher homocysteine concentrations in vege-
tarians and vegans are probably not a consequence of
folate deficiency but of cobalamin deficiency5. At the time
of blood sampling we considered plasma cobalamin
concentrations ,110 pmol l21 to be indicative of cobala-
min deficiency. Cobalamin deficiency can be divided into
four stages. In stages I and II, plasma and cell stores
become depleted. Stage III is indicated by increased
concentrations of homocysteine and methylmalonic acid.
Stage IV is characterised by elevated MCV and/or lowered
haemoglobin7. Since a low (total) cobalamin concen-
tration marks only the final stage of cobalamin deficiency,
this parameter is a late indicator of negative cobalamin
status. Therefore, higher concentrations should be used as
cut off-points11. Currently a number of different reference
levels have been suggested. Herrmann et al.2 used a
concentration of 156 pmol l21 as lower reference level.
Concentrations ,220 pmol l21 were considered to be
abnormal by Hokin and Butler32 and Herbert11, whereas
Spoelhof33 discussed a cobalamin concentration of
258 pmol l21 as cut-off point.
Cobalamin deficiency was found in 26% of the GVS
participants with a cut-off point of 110 pmol l21; nearly
three-quarters of these persons showed stage III cobalamin
deficiency and about half could be considered as stage IV
cobalamin-deficient. Serum cobalamin concentration
was ,156 pmol l21 in 52% of the investigated GVS
participants. This value is in agreement with Donaldson34.
He summarised findings from 12 studies concerning
cobalamin status in vegetarian/vegan diets, and found
overall that 50% of the studies’ participants could be
considered as cobalamin-deficient. Armstrong et al.35 and
Dong and Scott36 were able to show that cobalamin
concentrations decrease with increasing avoidance of
animal-derived products. In the GVS cohort, the moderate
vegans consumed only very small amounts of products of
animal origin, but even these small amounts of animal-
derived food were able to improve their cobalamin status.
The median cobalamin concentrations of GVS participants
were rather low compared with other studies. Herrmann
et al.2 reported median cobalamin concentrations of
217 pmol l21 without characterising the duration of the
vegan diet. Krajcovicova-Kudlackova et al.5 documented
mean concentrations of 140.1 pmol l21 for vegan and
214.8 pmol l21 for vegetarian subgroups. In their study, the
period of veganism/vegetarianism was quite long: 7.87 and
8.85 years, respectively. Haddad et al.8 reported an even
higher mean concentration of 312 pmol l21 for vegans. The
mean duration of veganism in their cohort was 4.2 years. In
agreement with Dong and Scott36 and Miller et al.37, our
results for the GVS cohort show a weak but significant
negative correlation between cobalamin concentration
and the duration of veganism (Spearman’s r ¼ 20.203,
P ¼ 0.013). The correlation analyses indicated a significant
inverse association for (log) cobalamin and (log) homo-
cysteine (r ¼ 20.602, P , 0.001) after controlling for
duration of vegan diet. These findings are in agreement
with other results that indicate an inverse association for
cobalamin and homocysteine2,3,5,14. Although studies with
omnivores show a strong inverse relationship for plasma
folate and homocysteine3,14 and, to a lesser extent,
associations between pyridoxine and homocysteine3, no
correlations between homocysteine and either pyridoxine
or folate, respectively, were found for the GVS participants.
These results bear analogy to those of Quinlivan et al.38,
who concluded that cobalamin is the main determinant of
homocysteine in cohorts with high folate intakes.
In conclusion, our findings show that even a small
amount of food of animal origin can improve cobalamin
and homocysteine status. In order to minimise the risk of
cobalamin deficiency and hyperhomocysteinaemia, regu-
lar supplementation of cobalamin in the nationally
recommended amount should be considered by strict
and moderate vegans.
Acknowledgements
This study was supported by the Stoll VITA Foundation,
Waldshut-Tiengen, Germany and the EDEN Foundation,
Bad Soden, Germany.
A.W. analysed the data and wrote the paper with the
co-authors. J.W.K. and A.H. co-ordinated the study, and
A Waldmann et al.470
organised blood sampling and data collection. A.H. and
C.L. originated and designed the study.
References
1 Boushey CJ, Beresford SA, Omenn GS, Motulsky AG.
A quantitative assessment of plasma homocysteine as a risk
factor for vascular disease. Probable benefits of increasing
folic acid intakes. Journal of the American Medical
Association 1995; 274: 1049–57.
2 Herrmann W, Schorr H, Purschwitz K, Rassoul F, Richter V.
Total homocysteine, vitamin B12 and total antioxidant
status in vegetarians. Clinical Chemistry 2001; 47:
1094–101.
3 Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH.
Vitamin status and intake as primary determinants of
homocysteinemia in an elderly population. Journal of the
American Medical Association 1993; 270: 2693–98.
4 Pietrzik K, Broenstrup A. Vitamins B12, B6 and folate as
determinants of homocysteine concentration in the healthy
population. European Journal of Pediatrics 1998;
157(Suppl. 2): 135S–8S.
5 Krajcovicova-Kudlackova M, Blazicek P, Kopcova J,
Bederova A, Babinska K. Homocysteine levels in vegetarians
versus omnivores. Annals of Nutrition & Metabolism 2000;
44: 135–8.
6 Koebnick C, Heins UA, Hoffmann I, Dagnelie PC,
Leitzmann C. Folate status during pregnancy in women is
improved by long-term high vegetable intake compared
with the average Western diet. Journal of Nutrition 2000;
131: 733–9.
7 Herbert V Vitamin B-12. In: Ziegler EE, Hiler LJ Jr, eds.
Present Knowledge in Nutrition. Washington, DC: ILSI Press,
1996; 191–205.
8 Haddad EH, Berk LS, Kettering JD, Hubbard RW, Peters WR.
Dietary intake and biochemical, hematologic, and
immune status of vegans compared with nonvegetarians.
American Journal of Clinical Nutrition 1999; 80(Suppl. 3):
586S–93S.
9 Abdulla M, Andersson I, Asp NG, Berthelsen K, Birkhed D,
Dencker I, et al. Nutrient intake and health status of vegans.
Chemical analyses of diets using the duplicate portion
sampling technique. American Journal of Clinical Nutrition
1981; 24: 2464–77.
10 Rauma AL, To¨rro¨nen R, Ha¨nninen O, Mykka¨nen H. Vitamin
B-12 status of long-term adherents of a strict uncooked
vegan diet (‘living food diet’) is compromised. Journal of
Nutrition 1995; 125: 2511–5.
11 Herbert V. Staging vitamin B-12 (cobalamin) status in
vegetarians. American Journal of Clinical Nutrition 1994;
59(Suppl. 5): 1213S–22S.
12 Alexander D, Ball MJ, Mann J. Nutrient intake and
haematological status of vegetarians and age–sex matched
omnivores. European Journal of Clinical Nutrition 1994; 48:
538–46.
13 Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S.
Homocyst(e)ine and cardiovascular disease: a critical review
of the epidemiologic evidence. Annals of Internal Medicine
1999; 131: 363–75.
14 Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH,
Stabler SP, et al. Homocysteine metabolism and risk of
myocardial infarction: relation with vitamins B6, B12 and
folate. American Journal of Epidemiology 1996; 143:
845–59.
15 Guttormsen AB, Schneede J, Ueland PM, Refsum H.
Kinetics of total plasma homocysteine in subjects with
hyperhomocysteinemia due to folate or cobalamin
deficiency. American Journal of Clinical Nutrition 1996;
63: 194–202.
16 Waldmann A, Koschizke JW, Leitzmann C, Hahn A. Dietary
intakes and lifestyle factors of a vegan population in
Germany: results from the German Vegan Study. European
Journal of Clinical Nutrition 2003; 57: 947–55.
17 Chen IW, Sperling MI, Heminger LA. Vitamin B12. In:
Pesce AJ, Kaplan LA, eds. Clinical Chemistry: Theory,
Analysis, and Correlation. St Louis, MO: CV Mosby, 1989;
569–73.
18 Brewster MA. Vitamins. In: Pesce AJ, Kaplan LA, eds. Clinical
Chemistry: Theory, Analysis, and Correlation. St Louis, MO:
CV Mosby, 1989; 543–68.
19 McNeely MD. Folic acid. In: Pesce AJ, Kaplan LA, eds.
Clinical Chemistry: Theory, Analysis, and Correlation.
St Louis, MO: CV Mosby, 1989; 539–42.
20 Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-
performance liquid chromatographic assay for total homo-
cysteine levels in human serum. Journal of Chromatography
1991; 565: 441–6.
21 Canham JE, Sauberlich HE, Baker EM, Raica J, Herman YE.
Biochemical assessment of the biochemical status of vitamin
B6 in the human. American Journal of Clinical Nutrition
1972; 25: 629–42.
22 International Committee for Standardization in Haematology
of the European Society of Haematology. Recommendations
and requirements for haemoglobin in human blood. Journal
of Clinical Pathology 1965; 18: 353.
23 Zijlstra WG, van Kampen EJ. Standardization of hemoglo-
binometry. III. Preparation and use of a stable hemi-
globin-cyanide standard. Clinica Chimica Acta 1962; 7:
96–9.
24 Zijlstra WG, van Kampen EJ. Standardization of hemoglo-
binometry. I. The extinction coefficient of hemiglobincya-
nide. Clinica Chimica Acta 1960; 5: 719–29.
25 Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine
and cardiovascular disease. Annual Review of Medicine
1998; 49: 31–62.
26 Stein JH, McBride EP. Hyperhomocysteinemia and athero-
sclerotic vascular disease. Archives of Internal Medicine
1998; 158: 1301–6.
27 Welch GN, Loscalzo J. Homocysteine and atherothrom-
bosis. New England Journal of Medicine 1998; 338:
1042–50.
28 Gerhard GT, Duell PB. Homocysteine and atherosclerosis.
Current Opinion in Lipidology 1999; 10: 417–28.
29 Woodside JV, Yarnell JW, McMaster D, Young IS, Harmon DL,
McCrum EE, et al. Effect of B-group vitamins and antioxidant
vitamins on hyperhomocysteinemia: a double-blind,
randomized, factorial-design, controlled trial. American
Journal of Clinical Nutrition 1996; 67: 858–66.
30 DeRose DJ, Charles-Marcel ZL, Jamison JM, Muscat JE,
Braman MA, McLane GD, et al. Vegan diet-based lifestyle
program rapidly lowers homocysteine levels. Preventive
Medicine 2000; 30: 225–33.
31 Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ,
Boers GH, Schellekens LA, et al. Plasma homocysteine and
menopausal status. European Journal of Clinical Investi-
gation 1995; 25: 801–5.
32 Hokin BD, Butler T. Cyanocobalamin (vitamin B-12) status
in Seventh-day Adventist ministers in Australia. American
Journal of Clinical Nutrition 1999; 70(Suppl. 3): 576S–8S.
33 Spoelhof GD. Reliability of serum B12-levels in the diagnosis
of B12-deficiency [Letter to the Editor]. American Family
Physician 1996; 54: 465–8.
34 Donaldson MS. Metabolic vitamin B-12 status on a mostly
raw vegan diet with follow-up using tablets, nutritional
yeast, or probiotic supplements. Annals of Nutrition &
Metabolism 2000; 44: 229–34.
35 Armstrong BK, Davis RE, Nivol DJ, van Merwyk AJ,
Larwood CJ. Hematological, vitamin B12 and folate studies
German Vegan Study: homocysteine and cobalamin 471
on Seventh-day Adventist vegetarians. American Journal of
Clinical Nutrition 1974; 27: 712–8.
36 Dong A, Scott SC. Serum vitamin B12 and blood-cell values
in vegetarians. Annals of Nutrition & Metabolism 1982; 4:
209–16.
37 Miller DR, Specker BL, Ho MI, Norman EJ. Vitamin B12 status
in a macrobiotic community. American Journal of Clinical
Nutrition 1991; 53: 524–9.
38 Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ,
Weir DG, et al. Importance of both folic acid and vitamin B12
in reduction of risk of vascular disease. Lancet 2002; 359:
227–8.
A Waldmann et al.472
